08 May 2026
CarboCell G/C provides sustained high local bone antibiotic levels with minimal systemic exposure, supporting its therapeutic potential in orthopedic infection management
J. Bone Joint Infect., 11, 257–265, 2026
12 May 2026
Adverse events and tolerability of long-term suppressive antibiotic therapy for periprosthetic joint infection: a prospective cohort study
J. Bone Joint Infect., 11, 267–275, 2026
18 May 2026
The use of debridement, antibiotic pearls, and implant retention (DAPRI) in the management of acute periprosthetic joint infections: a systematic review
J. Bone Joint Infect., 11, 277–285, 2026
19 May 2026
Can we identify which patients are likely to have septic arthritis with borderline synovial fluid cell counts?
J. Bone Joint Infect., 11, 287–297, 2026
22 May 2026
Nasal decolonization in total joint arthroplasty: current state of evidence
J. Bone Joint Infect., 11, 299–304, 2026
29 May 2026
Sinus tract and purulence as clinical criteria for periprosthetic joint infection: diagnostic accuracy, microorganisms, and clinical outcomes
J. Bone Joint Infect., 11, 305–313, 2026
03 Jun 2026
Tapping our resources: do preoperative aspirations add diagnostic value in hip and knee periprosthetic joint infection?
J. Bone Joint Infect., 11, 315–321, 2026
04 Jun 2026
High intra- and inter-observer reliability of the PJI-TNM classification in acute and chronic periprosthetic hip joint infection
J. Bone Joint Infect., 11, 323–330, 2026